Peptides DB
Research-centric peptide and protocol reference hub

Oxytocin vs Vasopressin

Updated August 24, 2026 · Reviewed by the PeptidesDB Editorial team

Oxytocin: FDA-approvedVasopressin: FDA-approved

A data-driven comparison of Oxytocin and Vasopressin (also searched as Vasopressin vs Oxytocin) — effect profiles, evidence, side effects, and which suits weight loss, muscle, or healing goals.

Verdict

Oxytocin centers on neuro, while Vasopressin leans toward neuro. On indexed research, Oxytocin is ahead (Oxytocin: 25 studies, Human clinical; Vasopressin: 24, Human clinical). Choose by goal — and read the primary studies. This is research information, not medical advice.

Key takeaways

  • Oxytocin is strongest for neuro; Vasopressin for neuro.
  • Evidence: Oxytocin Human clinical (25 studies) vs Vasopressin Human clinical (24).
  • Check the FDA-approval status chips above before assuming a legal use pathway.

Effect profiles, overlaid

OxytocinVasopressin

At a glance

OxytocinHuman clinical

Neuropeptide | Social bonding and emotional regulation

Strongest: NeuroStudies: 25Level: FDA Approved
VasopressinHuman clinical

Vasopressor | Blood pressure management

Strongest: NeuroStudies: 24Level: FDA Approved

Oxytocin vs Vasopressin: side-by-side

MetricOxytocinVasopressin
ClassNeuroMetabolic
Regulatory statusFDA-approvedFDA-approved
Evidence gradeHuman clinicalHuman clinical
Studies indexed2524
Research levelFDA ApprovedFDA Approved
Strongest effectNeuro & moodNeuro & mood
Healing & recovery2.02.0
Muscle & body comp1.01.0
Metabolic & appetite1.03.0
Neuro & mood5.04.0
Sleep & circadian2.02.0
Inflammation & immune1.03.0
Skin & aesthetics1.01.0

▲ marks the higher AI-assigned effect score (0–5, describing where the literature concentrates — not clinical efficacy).

Mechanism & pharmacokinetics

PropertyOxytocinVasopressin
MechanismOxytocin receptor agonistVasopressin receptor agonist (V1A and V2 receptors)
RouteIntravenous injection; Intranasal administrationSubcutaneous injection
Half-life~3–5 min~10–20 min
Time to peak30–120 min30–60 min
Duration of action1–2 hours2–8 hours

Established pharmacology — curated for well-characterized compounds and AI-summarized otherwise. A blank (—) means no reliable single value is published (half-life figures for some peptides genuinely disagree across sources). Verify against primary sources such as FDA labels and ClinicalTrials.gov.

What is Oxytocin?

Oxytocin is a neuropeptide that plays a crucial role in social bonding, reproductive behaviors, and emotional regulation. Its functions extend to various physiological processes, including childbirth and lactation, and it has garnered interest for its potential therapeutic applications in mental health and social disorders.

Full Oxytocin profile, mechanism & studies →

What is Vasopressin?

Research peptide discovered via AI researcher. peptide-based therapeutic

Full Vasopressin profile, mechanism & studies →

Which is better for your goal?

GoalBetter fitWhy
HealingEvenBoth ~2.0/5
MuscleEvenBoth ~1.0/5
MetabolicVasopressin3.0/5 effect signal
NeuroOxytocin5.0/5 effect signal
SleepEvenBoth ~2.0/5
InflammationVasopressin3.0/5 effect signal
SkinEvenBoth ~1.0/5

Fit reflects community-perceived effect profiles — not head-to-head trials. Read each peptide's studies before deciding.

Can you stack Oxytocin and Vasopressin?

People sometimes combine peptides that target different pathways, but there is little controlled research on this specific pairing and the interactions aren't well characterized. Because at least one is a research-use compound, we don't publish stacking or dosing protocols here. Any combination should be discussed with a qualified clinician.

Oxytocin vs Vasopressin: side effects

Oxytocin

No community-reported effects logged yet.

Vasopressin

No community-reported effects logged yet.

Anonymous community reports (count = number of reports), not clinical incidence rates.

What the research says

Oxytocin has 25 approved studies indexed (Human clinical), and Vasopressin has 24 (Human clinical). The Librarian re-checks PubMed, Europe PMC and ClinicalTrials daily, so these counts move. Open each profile to read the summaries and sources.

Frequently asked questions

Is Oxytocin or Vasopressin better?

It depends on your goal. Oxytocin is strongest for neuro; Vasopressin for neuro. Oxytocin has more indexed studies (25). See the goal-by-goal breakdown above.

Is Oxytocin or Vasopressin better for weight loss?

Vasopressin shows the stronger metabolic & appetite profile (3.0/5) in the AI-assigned effect profile — though weight-loss outcomes depend on the individual and the evidence base.

Is Oxytocin or Vasopressin better for muscle?

Both land close on the muscle & body-composition axis.

Which has more research, Oxytocin or Vasopressin?

Oxytocin has 25 approved studies indexed (Human clinical); Vasopressin has 24 (Human clinical). Higher counts mean more to read, not proven superiority.

Can you stack Oxytocin and Vasopressin?

Some users combine peptides, but there's little controlled data on this specific pairing, and interactions aren't well characterized. We don't publish stacking protocols for compounds that aren't FDA-approved. Discuss any combination with a qualified clinician.

What are the side effects of Oxytocin vs Vasopressin?

Oxytocin: no community-reported effects logged yet. Vasopressin: none logged yet. These are anonymous reports, not incidence rates — see each profile.

Is Oxytocin or Vasopressin FDA-approved?

Oxytocin is FDA-approved. Vasopressin is FDA-approved. Research-use status is not a legal clearance to compound or use in humans.

Is Vasopressin better than Oxytocin?

For neuro, Vasopressin has the edge; for neuro, Oxytocin does. Neither is universally "better" — it's goal-dependent, and both should be weighed against their evidence base above.

Comparing related peptides

Regulatory & legal status

Approval status varies (see the chips at the top). FDA approval and compounding rules for peptides change frequently, and research-use status is not a legal clearance for human use. The FDA does not review compounded drugs for safety, effectiveness, or quality. Verify current status with primary sources before acting. Last reviewed August 24, 2026.